Clinical Trial Detail

NCT ID NCT02536495
Title Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Erin Bertino
Indications

lung squamous cell carcinoma

Therapies

Docetaxel

Selinexor

Age Groups: adult

No variant requirements are available.